The DOI matches its Crossref record, with a small difference in title or year; 11 of the 11 references it cites were found in a registry or an index.
Time to weight plateau with tirzepatide treatment in the SURMOUNT ‐1 and SURMOUNT ‐4 clinical trials
Abstract
Summary: The rate of weight reduction during obesity treatment declines over time and eventually reaches a weight plateau. We investigated factors associated with time to weight plateau (TTWP) in tirzepatide‐treated participants with obesity or overweight in a post‐hoc analysis of SURMOUNT‐1 and SURMOUNT‐4 trials. Participants adherent to tirzepatide treatment and achieving ≥5% weight loss by primary endpoint (week 72 SURMOUNT‐1; week 88 SURMOUNT‐4) were included. Weight plateau was defined as a weight change <5% over a 12‐week interval and all subsequent 12‐week intervals. TTWP was time from randomization to the start of the first 12‐week interval. Association between baseline characteristics and TTWP was assessed. Overall, 1438 participants in SURMOUNT‐1 and 259 in SURMOUNT‐4 were included. Across BMI categories (overweight, class I, II, and III), median TTWP in SURMOUNT‐1 was 24.3, 26.0, 36.1, and 36.1 weeks, respectively ( p <.05, class II and III vs. overweight). By week 72, 90.2%, 88.9%, 87.6%, and 87.8% of participants in SURMOUNT‐1 had reached a weight plateau across respective BMI categories [Correction added on 22 January 2025, after first online publication: The “72%” has been changed to “72” in this version.]. Higher doses of tirzepatide (10/15 mg), younger age, and female sex were more likely to reach a weight plateau later. Results in SURMOUNT‐4 were similar. In this post‐hoc analysis, most participants reached a weight plateau by week 72. Higher doses of tirzepatide, younger age, and female sex were associated with a longer TTWP. Further research into modifiers of weight reduction phases with tirzepatide may inform treatment decisions for its use in chronic weight management. Clinical Trial Registration : ClinicalTrials.gov , identifiers NCT04184622 (SURMOUNT‐1) and NCT04660643 (SURMOUNT‐4), available at http://www.clinicaltrials.gov/
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Horn et al. [212] recently defined a ‘weight plateau’ as less than 5% weight loss in a 12-week period.”
From International Society of Sports Nutrition position stand: diets for body weight reduction (2026) · cites this paper as [212]
In the citing paper
“In the literature on populations with obesity, it is common for weight loss to be maximal at 6 months, after which point maintenance or regain occurs [212].”
From International Society of Sports Nutrition position stand: diets for body weight reduction (2026) · cites this paper as [212]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tirzepatide Once Weekly for the Treatment of Obesity
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206038 · Cited by 3,838
Self-citationGarvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Long-term persistence of hormonal adaptations to weight loss
Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105816 · Cited by 1,449
Wilding, J. P. H., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., Lingvay, I., McGowan, B. M., Oral, T. K., Rosenstock, J., et al. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14725 · Cited by 1,128
Self-citationCoskun, T., Sloop, K. W., Loghin, C., Alsina-Fernandez, J., Urva, S., Bokvist, K. B., Cui, X., Briere, D. A., Cabrera, O., Roell, W. C., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.09.009 · Cited by 882
Aronne, L. J., Sattar, N., Horn, D. B., Bays, H. E., Wharton, S., Lin, W.-Y., Ahmad, N. N., Zhang, S., Liao, R., Bunck, M. C., et al. (2024) · JAMA · doi:10.1001/jama.2023.24945 · Cited by 860
Self-citationWadden, T. A., Chao, A. M., Machineni, S., Kushner, R., Ard, J., Srivastava, G., Halpern, B., Zhang, S., Chen, J., Bunck, M. C., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02597-w · Cited by 442
Factors affecting weight loss variability in obesity
Dent, R., McPherson, R., & Harper, M.-E. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154388 · Cited by 131
New horizons. A new paradigm for treating to target with second-generation obesity medications
Garvey, W. T. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab848 · Cited by 110
Differential mechanisms affecting weight loss and weight loss maintenance
Rosenbaum, M., & Foster, G. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00864-1 · Cited by 61
Research works printed but not linked: 10
- 10.1016/j.mcna.2017.08.012 · DOI · Paper page
- 10.1016/s0140‐6736(23)01200‐x · DOI · Paper page
- 10.1002/oby.22154 · DOI
- 10.1002/oby.23612 · DOI
- National Academies of Sciences E and Medicine; Health and Medicine Division; Food and Nutrition Board.Translating Knowledge of Foundational Drivers of Obesity into Practice: Proceedings of a Workshop Series. National Academies Press (US).2023.
- 10.1038/ijo.2015.59 · DOI · Paper page
- 10.1038/s41574‐023‐00887‐4 · DOI
- 10.1002/oby.23905 · DOI
- 10.1038/sj.ijo.0803175 · DOI · Paper page
- 10.1001/jama.2021.3224 · DOI · Paper page
Cited by
International Society of Sports Nutrition position stand: diets for body weight reduction
Aragon, A. A., Campbell, B. I., Schoenfeld, B. J., Stout, J. R., Kalman, D., Arciero, P. J., Arent, S. M., Kreider, R. B., Taylor, L. W., Bannock, L., et al. (2026) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2026.2740266
Metadata
- Authors
- Horn, D. B., Kahan, S., Batterham, R. L., Cao, D., Lee, C. J., Murphy, M., Gonsahn‐Bollie, S., Chigutsa, F., Stefanski, A., & Dunn, J. P.
- Affiliations
- University of Texas, McGovern Medical School Houston Texas USA
- George Washington University School of Medicine Washington DC USA
- Eli Lilly and Company Indianapolis Indiana USA
- Venue
- Clinical Obesity
- Publisher
- Wiley
- Published
- 2025-01-12
- Volume
- 15
- Issue
- 3
- ISSN
- 1758-8103
- 1758-8111
- PMC
- PMC12096058
- Cited by
- 25
- References
- 11
- Language
- en
- Funders
- Eli Lilly and Company
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Time to weight plateau with tirzepatide treatment in the SURMOUNT ‐1 and SURMOUNT ‐4 clinical trials. https://app.cochat.ai/papers/10.1111/cob.12734
- The paper
- Horn, D. B., Kahan, S., Batterham, R. L., Cao, D., Lee, C. J., Murphy, M., Gonsahn‐Bollie, S., Chigutsa, F., Stefanski, A., & Dunn, J. P. (2025). Time to weight plateau with tirzepatide treatment in the SURMOUNT ‐1 and SURMOUNT ‐4 clinical trials. Clinical Obesity. https://doi.org/10.1111/cob.12734
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.